ANDA 76915, held by Watson Labs. Desogestrel; Ethinyl Estradiol.
As of Nov 16, 2026, ANDA 76915 (Desogestrel And Ethinyl Estradiol), held by Watson Labs, was first approved by FDA on Jul 29, 2005, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 29, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desogestrel And Ethinyl Estradiol0.15MG;0.03MG · tablet;oral-28 | Desogestrel; Ethinyl Estradiol | Rx |
| Apr 29, 2022 | Supplement 21Labeling · Standard review | Approved | None posted |
| Aug 9, 2017 | Supplement 20Labeling · Standard review | Approved | None posted |
| Apr 13, 2015 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jun 28, 2013 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jul 28, 2010 | Supplement 10Labeling | Approved | None posted |
| Jul 29, 2005 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters